Action CIPHER PHARMACEUTICALS INC
Ajouter à une liste
Instrument Inactif

Gouvernance Cipher Pharmaceuticals Inc Other OTC

Actions

CA17253X1050

Produits pharmaceutiques

Comité Exécutif: Cipher Pharmaceuticals Inc

Dirigeant
Fonctions occupéesDepuis
Craig Mull

Craig Mull

Chief Executive Officer 29/07/2019
Bryan Jacobs

Bryan Jacobs

President 10/08/2024
Corporate Secretary -
Emilio Presti

Emilio Presti

Sales & Marketing 01/07/2017
Shengnan Guo

Shengnan Guo

Comptroller/Controller/Auditor 01/02/2023
Ryan Mailling

Ryan Mailling

Director of Finance/CFO 10/08/2024
Graham Farrell

Graham Farrell

Investor Relations Contact -

Composition du Conseil d'Administration: Cipher Pharmaceuticals Inc

Administrateur
ComitésDepuis
Craig Mull

Craig Mull

Audit Committee 12/06/2019
Compensation Committee 12/06/2019
Hubert Walinski

Hubert Walinski

Compensation Committee 26/08/2025
Audit Committee Chair
Governance Committee Chair
Nominating Committee Chair
Douglas Deeth

Douglas Deeth

78 ans

Audit Committee
Governance Committee
Nominating Committee
Compensation Committee Chair
Rajiv de Silva

Rajiv de Silva

60 ans

Director/Board Member 21/09/2026
Independent Dir/Board Member 21/09/2026

Anciens Dirigeants et Administrateurs: Cipher Pharmaceuticals Inc

Insider
Fonctions occupées
DepuisJusqu'au
Harold Wolkin
Harold Wolkin
Director/Board Member 09/08/2016 25/08/2025
Independent Dir/Board Member 09/08/2016 25/08/2025
Hamed Ghanei
Hamed Ghanei
Corporate Officer/Principal 08/10/2024 -
Diane Gajewczyk
Diane Gajewczyk
Corporate Officer/Principal 05/06/2018 02/06/2023
Cathy Steiner
Cathy Steiner
Director/Board Member 08/10/2020 01/06/2023
Christian Godin
Christian Godin
Director/Board Member 09/08/2016 01/06/2023
Independent Dir/Board Member 09/08/2016 01/06/2023
Scott Langille
Scott Langille
Director of Finance/CFO 02/07/2020 15/08/2022
Nadine Jutlah
Nadine Jutlah
Director of Finance/CFO 29/03/2019 02/07/2020
Robert Tessarolo
Robert Tessarolo
Director/Board Member 11/05/2017 29/07/2019
Chief Executive Officer 17/04/2017 29/07/2019
President 17/04/2017 29/07/2019
Laurence Terrisse-Rulleau
Laurence Terrisse-Rulleau
Director/Board Member 10/05/2018 12/06/2019
Independent Dir/Board Member 10/05/2018 12/06/2019
Mark A. Beaudet
Mark A. Beaudet
Chairman 09/08/2016 12/06/2019
Independent Dir/Board Member 09/08/2016 12/06/2019
Stephen Lemieux
Stephen Lemieux
Chief Executive Officer 01/11/2016 01/04/2017
Director of Finance/CFO 12/09/2016 29/03/2019
Corporate Secretary 12/09/2016 29/03/2019
Michael Milloy
Michael Milloy
Corporate Officer/Principal 05/12/2018 -
Linda Angaritis
Linda Angaritis
Compliance Officer 01/01/2013 29/12/2017
Joan Chypyha
Joan Chypyha
President 01/03/2013 02/06/2017
Chris Watters
Chris Watters
Corporate Officer/Principal 02/06/2017 -
Ralph Bohrer
Ralph Bohrer
Corporate Officer/Principal 04/03/2016 01/06/2017
Stefan Aigner
Stefan Aigner
Director/Board Member 06/12/2007 11/05/2017
Independent Dir/Board Member 06/12/2007 11/05/2017
Arthur Deboeck
Arthur Deboeck
Director/Board Member 11/05/2017 -
Thomas Wellner
Thomas Wellner
Director/Board Member 25/03/2014 11/05/2017
Independent Dir/Board Member 12/03/2014 11/05/2017
Tuan Elstrom
Tuan Elstrom
Consultant / Advisor 01/01/2015 01/05/2017
Lynne Bulger
Lynne Bulger
Chief Tech/Sci/R&D Officer 20/01/2015 01/05/2017
Peter Weiler
Peter Weiler
Corporate Officer/Principal 01/01/2008 01/05/2017
Stephen R. Wiseman
Stephen R. Wiseman
Director/Board Member 03/08/2005 01/05/2017
Independent Dir/Board Member 03/08/2005 01/05/2017
Shawn O'Brien
Shawn O'Brien
Chief Executive Officer 30/06/2014 11/11/2016
President 30/06/2014 17/04/2017
Brian Rosenberger
Brian Rosenberger
Corporate Officer/Principal 02/06/2015 01/01/2017
Norman Evans
Norman Evans
Director of Finance/CFO 01/03/2007 12/09/2016
Corporate Secretary 01/03/2007 12/09/2016
Gerald McDole
Gerald McDole
Director/Board Member 23/02/2004 06/02/2014
Chairman 06/02/2014 09/08/2016
Independent Dir/Board Member 23/02/2004 09/08/2016
William D. Claypool
William D. Claypool
Director/Board Member 04/11/2009 09/08/2016
Independent Dir/Board Member 03/11/2009 09/08/2016
Rosemary Crane
Rosemary Crane
Director/Board Member 05/05/2016 09/08/2016
Renee Tannenbaum
Renee Tannenbaum
Director/Board Member 01/04/2016 09/08/2016
Louise Blythe
Louise Blythe
General Counsel 02/06/2015 01/04/2016
Joseph Pecora
Joseph Pecora
Corporate Officer/Principal 01/04/2015 01/12/2015
Charles F. Jenkins
Charles F. Jenkins
Sales & Marketing 01/04/2015 -
Michael Brooks
Michael Brooks
Corporate Officer/Principal 01/01/2010 01/01/2015
Larry Andrews
Larry Andrews
Director/Board Member 01/09/2004 30/06/2014
Chief Executive Officer 01/09/2004 30/06/2014
Investor Relations Contact 29/09/2011 30/06/2014
Public Communications Contact 17/07/2009 30/06/2014
President 01/09/2004 30/06/2014
Mark Spina
Mark Spina
Treasurer 01/04/2014 -
William Charles Garriock
William Charles Garriock
Chairman 23/02/2004 31/12/2013
Independent Dir/Board Member 29/09/2011 31/12/2013
John Donald MacInnis
John Donald MacInnis
Corporate Officer/Principal 27/10/2008 01/11/2011
Paul Thomas
Paul Thomas
Corporate Officer/Principal 01/01/2007 01/01/2008
Jason Gross
Jason Gross
Chief Tech/Sci/R&D Officer 16/06/2006 -
Steven W. Chepa
Steven W. Chepa
Director/Board Member 24/05/2006 -
John Mull
John Mull
Director/Board Member 09/01/2004 -
Independent Dir/Board Member 09/01/2004 -
Waldemar Zimmerman
Waldemar Zimmerman
Director/Board Member 09/01/2004 -
Patrice Merrin
Patrice Merrin
Director/Board Member 06/04/2009 -
Joseph Fairbrother
Joseph Fairbrother
Director/Board Member 06/04/2009 -
James Bowen
James Bowen
Investor Relations Contact - -
Karen Vonzitzewitz
Karen Vonzitzewitz
Corporate Officer/Principal - -
Blair Gordon
Blair Gordon
Corporate Officer/Principal - -

Distribution de l'Âge des Dirigeants

Parité Homme Femme

Homme8
Femme1

Dont comité exécutif

Homme5
Femme1

Dont Administrateurs

Homme4
Femme0

Profil Société

Logo Cipher Pharmaceuticals Inc
Cipher Pharmaceuticals Inc. est une société pharmaceutique spécialisée basée au Canada qui dispose d’un portefeuille diversifié de produits commercialisés et de produits à différents stades de développement, de la phase précoce à la phase avancée. La société acquiert des produits, gère le développement clinique et les procédures d’autorisation réglementaires nécessaires, puis commercialise ces produits, soit directement, soit indirectement, au Canada, aux États-Unis et en Amérique du Sud. Les catégories de produits de la société comprennent la dermatologie, les soins hospitaliers aigus, les produits sous licence et la médecine spécialisée. Ses produits dermatologiques comprennent Actikerall, Epuris, Vaniqa et Natroba. Ses produits destinés aux soins hospitaliers aigus comprennent Aggrastat et Brinavess. Ses produits sous licence comprennent Absorica, ConZip et Lipofen. Absorica (isotrétinoïne) est un rétinoïde oral. Durela, son médicament de spécialité, est un analgésique opioïde indiqué pour la prise en charge de la douleur modérée à modérément sévère chez les adultes nécessitant un traitement continu pendant plusieurs jours ou plus. Ses produits en cours de développement comprennent le Piclidenoson CF-101, le MOB-015 et le DTR-001.
Employés
-
Secteur
Produits pharmaceutiques
Plus d'informations sur la société

Départs de Personnes Clées

Robert Tessarolo
-
Robert Tessarolo

Chief Executive Officer

17/04/2017 29/07/2019

Mark A. Beaudet
-
Mark A. Beaudet

Chairman

09/08/2016 12/06/2019

Stephen Lemieux
-
Stephen Lemieux

Chief Executive Officer

01/11/2016 01/04/2017

Shawn O'Brien
-
Shawn O'Brien

Chief Executive Officer

30/06/2014 11/11/2016

Gerald McDole
-
Gerald McDole

Chairman

06/02/2014 09/08/2016

Larry Andrews
-
Larry Andrews

Chief Executive Officer

01/09/2004 30/06/2014

William Charles Garriock
-
William Charles Garriock

Chairman

23/02/2004 31/12/2013

  1. Bourse
  2. Actions
  3. Action CPH
  4. Action
  5. Société Cipher Pharmaceuticals Inc
  6. Gouvernance
🔇

Sélectionnez votre édition

Toutes les informations financières adaptées au niveau national

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong